But certain medication errors tied to GLP-1s have exploded too, according to a KFF Health News review of Food and Drug Administration data, and physicians and telemedicine researchers worry that adverse experiences tied to telehealth companies are becoming more common
February 17, 2026
Among GLP-1RA users, 26.36% discontinued treatment during follow-up, while 22.68% experienced interruptions
[DOI] [PubMed] [Google Scholar] 14.Wilding J.P.H., Batterham R.L., Calanna S., Davies M., Van Gaal L.F., Lingvay I., Mcgowan B.M., Rosenstock J., Tran M.T.D., Wadden T.A., et al
Other supportive lifestyle interventions Other lifestyle interventions are essential to support individuals using GLP-1s as part of the recommended multicomponent lifestyle programs that are the foundation of obesity treatment [88,171,172]
Mounjaro: Mounjaro, on the other hand, takes a more comprehensive approach